Hospital
New Manna CLG, LLC
New Manna CLG, LLC was paid $246K by Medicaid between Nov 2019 and Dec 2024, across 61 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoNEW MANNA CLG, LLC
BEACHWOOD, OH 44122
BEACHWOOD, OH 44122
33aNPI1841789427assigned 05/09/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$246K
24GClaims21,002
24DCodes billed61
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#97 of 101
Median peer was paid$22.32M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 47 | $0.65 | |
| 2020 | 914 | $69.96 | |
| 2021 | 411 | $128.25 | |
| 2022 | 250 | $6K | |
| 2023 | 10,666 | $137K | |
| 2024incomplete | 8,714 | $103K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 895 | 765 | $72K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 503 | 408 | $45K |
| 96361 | Intravenous infusion, hydration; each additional hour | 18% | 201 | 153 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.9% | 365 | 358 | $19K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 304 | 288 | $16K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 244 | 89 | $8K |
| 64415 | 2.4% | 43 | 39 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.4% | 170 | 168 | $6K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.3% | 51 | 35 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.9% | 87 | 79 | $5K |
| 80053 | Comprehensive metabolic panel | 1.8% | 721 | 583 | $4K |
| 64483 | <1% | 12 | 12 | $2K |
49 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 184 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 89 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 844 | $2K |
| 85610 | <1% | 189 | $1K | |
| 81001 | <1% | 440 | $698.12 | |
| 85730 | <1% | 171 | $682.95 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 39 | $650.39 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 204 | $525.67 |
| 73130 | <1% | 46 | $500.75 | |
| J3490 | Unclassified drugs | <1% | 244 | $414.63 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 119 | $392.52 |
| 87641 | <1% | 13 | $357.49 | |
| 73110 | <1% | 16 | $224.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,009 | $223.82 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 43 | $144.54 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 76 | $100.34 |
| 72100 | <1% | 209 | $75.02 | |
| 82947 | <1% | 67 | $67.26 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 182 | $55.51 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 535 | $49.68 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,848 | $47.80 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 93 | $43.73 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 311 | $27.75 |
| 81025 | <1% | 531 | $25.65 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 959 | $22.69 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,453 | $21.01 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,443 | $19.50 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 191 | $15.59 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,143 | $12.00 |
| 81003 | <1% | 43 | $8.93 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,195 | $8.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,218 | $3.83 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 168 | $3.33 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 132 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 137 | $0.00 |
| 94760 | 0% | 19 | $0.00 | |
| 84484 | 0% | 45 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 468 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 63 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 12 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 25 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 12 | $0.00 |
| 85027 | 0% | 17 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 90 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 261 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 497 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 168 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 109 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRACZ, ROBERT (CFO)
| Provider | Location | Paid |
|---|---|---|
| Lake Hospital System INC | Middlefield, OH | $6.89M |
| Lake Hospital System, INC. | Mentor, OH | $249K |
| Lake Hospital System, INC | Mentor, OH | $8K |
| Lake Hospital System, INC | Painesville, OH | $7K |
| Lake Hospital System, INC | Chardon, OH | $2K |
| Lake Hospital System INC. | Concord Twp, OH | $458.68 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.